"Misdirection" seems to be the new catch phrase. Every response seems to labeled 'distraction' or 'misdirection'. The reality is that posters try to give guidance on how to get answers to the questions, but there is never any follow-through.
For who owns the shares, contact the tranfer agent.
For clinical trial financing, contact Barry Hall or Mike Irving.
As for myself, I don't care who owns the shares and I don't care where they got the money for the clinical trials. The important thing is that the clinical trials are complete and results are due out soon.
As for "misdirection", would not modifying a Consumer Reports article to falsely implicate Roth be misdirection? How about an FDA youtube video that does not apply either?
I suggest that everyone keep their eye on the ball and watch for clinical trial results in the next couple weeks.
News 
Market Data 
Discover 
